Insider · CIK 0001204260

BIANCO LOUIS A

Reports to the SEC for 1 company · SEATTLE, WA

sec.gov

Transactions

Companies

Filings

CIK

0001204260

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2016-03-21	CTI BIOPHARMA CORPF Tax Payment	EVP, Finance & Administration	FTax Payment	−46.6K sh	$0.55	−$25.5K	622,933
2015-12-23	CTI BIOPHARMA CORPEmployee Stock Option (Right to Buy)A Award	EVP, Finance & Administration	AAward	+1.6M sh	—	—	1,600,000
2015-12-23	CTI BIOPHARMA CORPD Disposition to Issuer	EVP, Finance & Administration	DDisposition to Issuer	−237K sh	—	—	669,489
2015-11-19	CTI BIOPHARMA CORPS Sale	EVP, Finance & Administration	SSale	−100 sh	$1.14	−$113.5	911,847
2015-11-19	CTI BIOPHARMA CORPS Sale	EVP, Finance & Administration	SSale	−2,994 sh	$1.15	−$3,428.13	908,047
2015-11-19	CTI BIOPHARMA CORPS Sale	EVP, Finance & Administration	SSale	−100 sh	$1.16	−$116	906,347
2015-11-19	CTI BIOPHARMA CORPS Sale	EVP, Finance & Administration	SSale	−1,000 sh	$1.12	−$1,120	914,147
2015-11-19	CTI BIOPHARMA CORPS Sale	EVP, Finance & Administration	SSale	−200 sh	$1.11	−$223	915,147
2015-11-19	CTI BIOPHARMA CORPS Sale	EVP, Finance & Administration	SSale	−1,100 sh	$1.16	−$1,270.5	906,447
2015-11-19	CTI BIOPHARMA CORPS Sale	EVP, Finance & Administration	SSale	−1,400 sh	$1.10	−$1,547	919,147
2015-11-19	CTI BIOPHARMA CORPS Sale	EVP, Finance & Administration	SSale	−806 sh	$1.14	−$918.84	911,041
2015-11-19	CTI BIOPHARMA CORPS Sale	EVP, Finance & Administration	SSale	−500 sh	$1.15	−$575	907,547
2015-11-19	CTI BIOPHARMA CORPS Sale	EVP, Finance & Administration	SSale	−800 sh	$1.10	−$880	920,547
2015-11-19	CTI BIOPHARMA CORPS Sale	EVP, Finance & Administration	SSale	−3,800 sh	$1.11	−$4,218	915,347
2015-11-19	CTI BIOPHARMA CORPS Sale	EVP, Finance & Administration	SSale	−1,200 sh	$1.13	−$1,356	911,947
2015-11-19	CTI BIOPHARMA CORPS Sale	EVP, Finance & Administration	SSale	−1,000 sh	$1.13	−$1,125	913,147
2015-10-29	CTI BIOPHARMA CORPS Sale	EVP, Finance & Administration	SSale	−100 sh	$1.43	−$142.5	921,547
2015-10-29	CTI BIOPHARMA CORPS Sale	EVP, Finance & Administration	SSale	−200 sh	$1.43	−$286	921,347
2015-10-29	CTI BIOPHARMA CORPS Sale	EVP, Finance & Administration	SSale	−500 sh	$1.42	−$711.25	921,647
2015-10-29	CTI BIOPHARMA CORPS Sale	EVP, Finance & Administration	SSale	−100 sh	$1.40	−$140.25	927,147
2015-10-29	CTI BIOPHARMA CORPS Sale	EVP, Finance & Administration	SSale	−800 sh	$1.40	−$1,120	927,247
2015-10-29	CTI BIOPHARMA CORPS Sale	EVP, Finance & Administration	SSale	−300 sh	$1.41	−$423	926,847
2015-10-29	CTI BIOPHARMA CORPS Sale	EVP, Finance & Administration	SSale	−2,200 sh	$1.39	−$3,058	928,047
2015-10-29	CTI BIOPHARMA CORPS Sale	EVP, Finance & Administration	SSale	−4,700 sh	$1.42	−$6,674	922,147
2015-10-29	CTI BIOPHARMA CORPS Sale	EVP, Finance & Administration	SSale	−1,100 sh	$1.38	−$1,518	930,247
2015-10-22	CTI BIOPHARMA CORPS Sale	EVP, Finance & Administration	SSale	−10K sh	$1.58	−$15.8K	931,347
2015-09-29	CTI BIOPHARMA CORPS Sale	EVP, Finance & Administration	SSale	−5,647 sh	$1.47	−$8,301.09	941,347
2015-09-29	CTI BIOPHARMA CORPS Sale	EVP, Finance & Administration	SSale	−3,457 sh	$1.46	−$5,047.22	946,994
2015-09-29	CTI BIOPHARMA CORPS Sale	EVP, Finance & Administration	SSale	−1,120 sh	$1.44	−$1,612.8	950,451
2015-09-29	CTI BIOPHARMA CORPS Sale	EVP, Finance & Administration	SSale	−7,259 sh	$1.43	−$10.4K	951,571
2015-09-29	CTI BIOPHARMA CORPS Sale	EVP, Finance & Administration	SSale	−7,878 sh	$1.43	−$11.2K	958,830
2015-09-29	CTI BIOPHARMA CORPS Sale	EVP, Finance & Administration	SSale	−20.1K sh	$1.42	−$28.6K	966,708
2015-09-29	CTI BIOPHARMA CORPS Sale	EVP, Finance & Administration	SSale	−100 sh	$1.42	−$141.5	986,848
2015-09-29	CTI BIOPHARMA CORPS Sale	EVP, Finance & Administration	SSale	−44.2K sh	$1.41	−$62.3K	986,948
2015-09-29	CTI BIOPHARMA CORPS Sale	EVP, Finance & Administration	SSale	−15.7K sh	$1.41	−$22K	1,031,148
2015-09-29	CTI BIOPHARMA CORPS Sale	EVP, Finance & Administration	SSale	−31.1K sh	$1.40	−$43.6K	1,046,798
2015-09-29	CTI BIOPHARMA CORPS Sale	EVP, Finance & Administration	SSale	−22.2K sh	$1.39	−$30.9K	1,077,947
2015-09-29	CTI BIOPHARMA CORPS Sale	EVP, Finance & Administration	SSale	−100 sh	$1.39	−$138.5	1,100,147
2015-09-29	CTI BIOPHARMA CORPS Sale	EVP, Finance & Administration	SSale	−11.1K sh	$1.38	−$15.3K	1,100,247
2015-09-24	CTI BIOPHARMA CORPS Sale	EVP, Finance & Administration	SSale	−10K sh	$1.52	−$15.2K	1,111,347
2015-09-21	CTI BIOPHARMA CORPA Award	EVP, Finance & Administration	AAward	+206K sh	—	—	1,121,347
2015-07-23	CTI BIOPHARMA CORPS Sale	EVP, Finance & Administration	SSale	−10K sh	$1.91	−$19.1K	915,416
2015-06-25	CTI BIOPHARMA CORPS Sale	EVP, Finance & Administration	SSale	−10K sh	$2.18	−$21.8K	925,416
2015-05-21	CTI BIOPHARMA CORPS Sale	EVP, Finance & Administration	SSale	−10K sh	$1.80	−$18K	935,416
2015-04-23	CTI BIOPHARMA CORPS Sale	EVP, Finance & Administration	SSale	−10K sh	$1.93	−$19.3K	945,416
2015-03-21	CTI BIOPHARMA CORPF Tax Payment	EVP, Finance & Administration	FTax Payment	−66.7K sh	$1.94	−$129K	955,416
2015-03-20	CTI BIOPHARMA CORPS Sale	EVP, Finance & Administration	SSale	−10K sh	$1.92	−$19.2K	1,075,152
2015-03-20	CTI BIOPHARMA CORPS Sale	EVP, Finance & Administration	SSale	−1,300 sh	$1.92	−$2,499.9	1,073,852
2015-03-20	CTI BIOPHARMA CORPS Sale	EVP, Finance & Administration	SSale	−5,100 sh	$1.94	−$9,909.3	1,035,752
2015-03-20	CTI BIOPHARMA CORPS Sale	EVP, Finance & Administration	SSale	−15.9K sh	$1.93	−$30.7K	1,057,952

Recent filings

Accepted (ET)
Mar 234
CTI BIOPHARMA CORP0000891293-16-000134
SEC(opens sec.gov)
Dec 234
CTI BIOPHARMA CORP0000891293-15-000075
SEC(opens sec.gov)
Nov 204
CTI BIOPHARMA CORP0000891293-15-000059
SEC(opens sec.gov)
Oct 304
CTI BIOPHARMA CORP0000891293-15-000056
SEC(opens sec.gov)

Companies

CTI BIOPHARMA CORPEVP, Finance & Administration

Address

501 ELLIOT AVENUE WEST SUITE 400

SEATTLE, WA, 98119